about
Adenovirus 36 and Obesity: An OverviewThe Microbial Hypothesis: Contributions of Adenovirus Infection and Metabolic Endotoxaemia to the Pathogenesis of ObesityE4orf1: a novel ligand that improves glucose disposal in cell cultureSerological data analyses show that adenovirus 36 infection is associated with obesity: a meta-analysis involving 5739 subjects.Seroprevalence of 13 common pathogens in a rapidly growing U.S. minority population: Mexican Americans from San Antonio, TXAssociation of adenovirus 36 infection with obesity and metabolic markers in humans: a meta-analysis of observational studies.Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids.Role of adenoviruses in obesity.A human adenovirus enhances preadipocyte differentiation.A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).Could a virus contribute to weight gain?Harnessing the beneficial properties of adipogenic microbes for improving human health.Template to improve glycemic control without reducing adiposity or dietary fat.Genetic factors influence serological measures of common infections.Promising new causal explanations for obesity and obesity-related diseases.Infectivity period of mice inoculated with human adenovirusesInsulin receptor-independent upregulation of cellular glucose uptakeAdenovirus-36 seropositivity and its relation with obesity and metabolic profile in children.Infeccions as the etiology for obesity.Chlamydia pneumoniae infection is associated with elevated body mass index in young men.Infection-induced inflammatory response of adipocytes in vitro.New insights into how adenovirus might lead to obesity: An oxidative stress theory.Oxidative stress and inflammation interactions in human obesity.Obesity and infection: two sides of one coin.Gene expression profile in human skeletal muscle cells infected with human adenovirus type 36.An infection of human adenovirus 31 affects the differentiation of preadipocytes into fat cells, its metabolic profile and fat accumulation.Adenovirus type 9 enhances differentiation and decreases cytokine release from preadipocytes.Adipogenic cascade can be induced without adipogenic media by a human adenovirus.Regulation of PPARγ and CIDEC expression by adenovirus 36 in adipocyte differentiation.Characteristics of adipose tissue macrophages and macrophage-derived insulin-like growth factor-1 in virus-induced obesity.Adenovirus 36 infection: a role in dietary intake and response to inpatient weight management in obese girls.Adenovirus 36 DNA in human adipose tissue.The relationship between adenovirus-36 seropositivity, obesity and metabolic profile in Turkish children and adults.Longitudinal investigation of adenovirus 36 seropositivity and human obesity: the Cardiovascular Risk in Young Finns Study.Human adenovirus-36 is uncommon in type 2 diabetes and is associated with increased insulin sensitivity in adults in Sweden.Proof-of-concept for a virus-induced obesity vaccine; vaccination against the obesity agent adenovirus 36.Lack of adenovirus DNA in mediastinal adipose tissue of obese/overweight adults with cardiovascular disorders?Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells.Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes.Human adenovirus-36 and childhood obesity.
P2860
Q26799943-B1990129-B46E-49EB-B2DF-DB09E1285519Q28067835-11CED5DF-C087-4C9D-AF08-BDE8D44E86BBQ28741118-4FE41B86-A083-4B96-9D33-B3249D4A5707Q30651817-18033E41-0211-4437-AAB1-7F2806A1D271Q34054025-E5DEA0D4-4417-437A-9BD4-FF544785FE06Q34359430-59B55E17-87AE-43E9-93B7-D01EC7E4EB8BQ34378590-2862A118-6B3D-495C-B873-2ABC9A0BEBA0Q34493305-B4417562-C000-4D65-9E22-8A47ABAF1E78Q34548223-DE8B80BD-2243-456A-9A01-0CA6E6C12149Q34550781-30C5E81B-B71B-406F-84E6-1267C8A25E5BQ34617585-91CD7CD9-3CF5-4943-BBEA-AEE2F74EA0E6Q34714843-BEA18908-28D2-4D7F-AAAE-8627D867A060Q34979386-83363D9D-41A6-4381-B2AF-A760110A25C9Q35546399-D7ECBBE0-E936-4EA2-8FB3-8BBB35E7EF3DQ36685482-6C25B217-061E-4730-93BC-6CA5869C58A4Q36817766-93915137-4D4B-482C-9B70-A82A3AF4CD17Q36826889-A1194101-680E-47BF-BC95-034043C35289Q37353633-DD7D4E48-A6A4-4658-BC16-D77FC86F211AQ37494284-9A248060-A96B-4367-B66E-1B8ED7930F2CQ37853903-55958247-EDFB-4227-98D5-02E24975D805Q37857830-59867ECF-94A1-4ABE-8584-91816801FEBEQ37880106-32230F92-504C-4D04-8063-5567DD537992Q37986642-0D1CAD08-02E0-4C64-9209-9FE6FC4502F5Q38154513-96498D3A-3A3E-4B67-B3EA-451075D83710Q38411386-3BE4D4B4-B365-44FD-AB48-1B3EE062F8ECQ38841740-FECA0A21-AA37-4F5F-A9E0-FC58A2D8B69CQ38979652-56099908-28A8-4A62-BE4E-179FCC16677EQ39891667-4FA56F8E-83E7-4F85-AE61-D6C5540FBEB5Q40403091-CD118B9A-4298-489C-A982-922A01CF1559Q40512953-BAF23839-E267-4C19-AACD-80F1C1F478F7Q41035719-320F1104-77B7-4836-8842-BB5D95EA25B4Q41041135-BD76F0E8-5877-4948-A08C-63CB5137FB6BQ41069406-137B3EC0-016A-4FAE-8880-CD01CE4D871CQ41175787-F8CB295A-4861-424F-AEC6-4CCB8307B850Q42204806-466374D7-F2A0-4222-8351-F604B2848E34Q42232577-FBF1F588-DED7-44D1-965A-62B62C2E996FQ42255126-50A473BB-D658-4FC8-96FD-B7CF1890440AQ42801909-6D302EEE-C196-4B6C-9F20-201E02B348E0Q42802641-C978BA05-6ACD-4ECA-A43E-391E4BDC100CQ44156650-3F6F5FD7-19C4-4887-98A1-537660D48246
P2860
description
article
@en
im August 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2000
@uk
ലേഖനം
@ml
name
Increased adiposity in animals due to a human virus
@en
Increased adiposity in animals due to a human virus
@nl
type
label
Increased adiposity in animals due to a human virus
@en
Increased adiposity in animals due to a human virus
@nl
prefLabel
Increased adiposity in animals due to a human virus
@en
Increased adiposity in animals due to a human virus
@nl
P2093
P2860
P356
P1476
Increased adiposity in animals due to a human virus
@en
P2093
JM Kolesar
NV Dhurandhar
RL Atkinson
P2860
P2888
P304
P356
10.1038/SJ.IJO.0801319
P407
P577
2000-08-01T00:00:00Z